Michael Egholm - 22 May 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Key filing fact

Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 27 May 2025.

Key facts

This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 27 May 2025, 20:28.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001559779 Primary reporting owner

Relationship: President & CEO, Director
Address: C/O STANDARD BIOTOOLS INC., 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO
Signature: /s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact
Signature date: 27 May 2025

LAB transaction

Sale

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission ("SEC") on March 24, 2025.
F2	Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.